New method for the treatment of inflammatory diseases
WO2006077232A2
Multimeric soluble fas ligand for eliminating alloreactive t lymphocyte in allogenic harmatopoietic stem-cell transplantation transplantation
WO2007077042A1
New method for the treatment of gout or pseudogout
MX2007004058A
Method for ex-vivo purging in autologous transplantation.
EP1746167A1
Method for the identification of compounds susceptible to inhibit inflammation
BRPI0511683A
method for preventing or reducing adverse effects on the liver of a patient treated with a fas mediated apoptosis inducing agent, pharmaceutical compositions, and treatment kit
EP1481686A1
Use of multimeric ligands of the TNF family with reduced toxicity for treating cell proliferative diseases
AU2002333502A1
Fusion constructs containing active sections of tnf ligands
EP1366071A2
Dna-sequences, which code for an apoptosis signal transduction protein
EP1349933A2
Proteins and dna sequences underlying these proteins used for treating inflammations
